Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 475

1.

An Assessment of Melatonin's Therapeutic Value in the Hypoxic-Ischemic Encephalopathy of the Newborn.

Cardinali DP.

Front Synaptic Neurosci. 2019 Dec 10;11:34. doi: 10.3389/fnsyn.2019.00034. eCollection 2019. Review.

2.

Understanding the role of sleep and its disturbances in Autism spectrum disorder.

Karthikeyan R, Cardinali DP, Shakunthala V, Spence DW, Brown GM, Pandi-Perumal SR.

Int J Neurosci. 2020 Jan 14:1-14. doi: 10.1080/00207454.2019.1711377. [Epub ahead of print]

PMID:
31903819
3.

Melatonin: Clinical Perspectives in Neurodegeneration.

Cardinali DP.

Front Endocrinol (Lausanne). 2019 Jul 16;10:480. doi: 10.3389/fendo.2019.00480. eCollection 2019. Review.

4.

Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer's Disease and Melatonin.

Spinedi E, Cardinali DP.

Neuroendocrinology. 2019;108(4):354-364. doi: 10.1159/000494889. Epub 2018 Oct 28. Review.

5.

The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy.

Spinedi E, Cardinali DP.

Int J Endocrinol. 2018 Jul 25;2018:1349868. doi: 10.1155/2018/1349868. eCollection 2018. Review.

6.

Sleep and circadian rhythms in health and disease: a complex interplay.

Zaki NFW, Spence DW, BaHammam AS, Pandi-Perumal SR, Cardinali DP, Brown GM.

Eur Arch Psychiatry Clin Neurosci. 2019 Apr;269(3):365-366. doi: 10.1007/s00406-018-0866-6. Epub 2018 Jan 20. No abstract available.

PMID:
29353370
7.

Chronobiological theories of mood disorder.

Zaki NFW, Spence DW, BaHammam AS, Pandi-Perumal SR, Cardinali DP, Brown GM.

Eur Arch Psychiatry Clin Neurosci. 2018 Mar;268(2):107-118. doi: 10.1007/s00406-017-0835-5. Epub 2017 Sep 11. Review.

PMID:
28894915
8.

Melatonin, mitochondria, and the metabolic syndrome.

Cardinali DP, Vigo DE.

Cell Mol Life Sci. 2017 Nov;74(21):3941-3954. doi: 10.1007/s00018-017-2611-0. Epub 2017 Aug 17. Review.

PMID:
28819865
9.

The influence of intermittent fasting on the circadian pattern of melatonin while controlling for caloric intake, energy expenditure, light exposure, and sleep schedules: A preliminary report.

Almeneessier AS, Bahammam AS, Sharif MM, Bahammam SA, Nashwan SZ, Pandi Perumal SR, Cardinali DP, Alzoghaibi M.

Ann Thorac Med. 2017 Jul-Sep;12(3):183-190. doi: 10.4103/atm.ATM_15_17.

10.

Comparative analysis of actigraphy performance in healthy young subjects.

Bellone GJ, Plano SA, Cardinali DP, Chada DP, Vigo DE, Golombek DA.

Sleep Sci. 2016 Oct-Dec;9(4):272-279. doi: 10.1016/j.slsci.2016.05.004. Epub 2016 Jun 20.

11.

Preface.

Spinedi E, Cardinali DP, Gagliardino JJ.

Neuroendocrinology. 2017;104(4):317-318. doi: 10.1159/000455076. Epub 2016 Dec 23. No abstract available.

PMID:
28006771
12.

Melatonin and Human Cardiovascular Disease.

Pandi-Perumal SR, BaHammam AS, Ojike NI, Akinseye OA, Kendzerska T, Buttoo K, Dhandapany PS, Brown GM, Cardinali DP.

J Cardiovasc Pharmacol Ther. 2017 Mar;22(2):122-132. doi: 10.1177/1074248416660622. Epub 2016 Jul 27.

PMID:
27450357
13.

Inflammaging, Metabolic Syndrome and Melatonin: A Call for Treatment Studies.

Cardinali DP, Hardeland R.

Neuroendocrinology. 2017;104(4):382-397. doi: 10.1159/000446543. Epub 2016 May 11. Review.

PMID:
27165273
14.

Assessing the efficacy of melatonin to curtail benzodiazepine/Z drug abuse.

Cardinali DP, Golombek DA, Rosenstein RE, Brusco LI, Vigo DE.

Pharmacol Res. 2016 Jul;109:12-23. doi: 10.1016/j.phrs.2015.08.016. Epub 2015 Oct 9. Review.

PMID:
26438969
15.

The impact of home safety on sleep in a Latin American country.

Simonelli G, Patel SR, Rodríguez-Espínola S, Pérez-Chada D, Salvia A, Cardinali DP, Vigo DE.

Sleep Health. 2015 Jun;1(2):98-103. doi: 10.1016/j.sleh.2015.02.006. Epub 2015 Apr 8.

PMID:
29073385
16.

Some implications of melatonin use in chronopharmacology of insomnia.

Golombek DA, Pandi-Perumal SR, Brown GM, Cardinali DP.

Eur J Pharmacol. 2015 Sep 5;762:42-8. doi: 10.1016/j.ejphar.2015.05.032. Epub 2015 May 21. Review.

PMID:
26004526
17.

Melatonin counteracts changes in hypothalamic gene expression of signals regulating feeding behavior in high-fat fed rats.

Ríos-Lugo MJ, Jiménez-Ortega V, Cano-Barquilla P, Mateos PF, Spinedi EJ, Cardinali DP, Esquifino AI.

Horm Mol Biol Clin Investig. 2015 Mar;21(3):175-83. doi: 10.1515/hmbci-2014-0041.

PMID:
25719335
18.

Melatonin and brain inflammaging.

Hardeland R, Cardinali DP, Brown GM, Pandi-Perumal SR.

Prog Neurobiol. 2015 Apr;127-128:46-63. doi: 10.1016/j.pneurobio.2015.02.001. Epub 2015 Feb 16. Review.

PMID:
25697044
19.

Association of Per3 length polymorphism with bipolar I disorder and schizophrenia.

Karthikeyan R, Marimuthu G, Ramasubramanian C, Arunachal G, BaHammam AS, Spence DW, Cardinali DP, Brown GM, Pandi-Perumal SR.

Neuropsychiatr Dis Treat. 2014 Dec 9;10:2325-30. doi: 10.2147/NDT.S73765. eCollection 2014.

20.

Melatonin and diet-induced metabolic syndrome in rats: impact on the hypophysial-testicular axis.

Bernasconi PA, Cardoso NP, Reynoso R, Scacchi P, Cardinali DP.

Horm Mol Biol Clin Investig. 2013 Dec;16(2):101-12. doi: 10.1515/hmbci-2013-0005.

PMID:
25436751
21.

Per3 length polymorphism in patients with type 2 diabetes mellitus.

Karthikeyan R, Marimuthu G, Sooriyakumar M, BaHammam AS, Spence DW, Pandi-Perumal SR, Brown GM, Cardinali DP.

Horm Mol Biol Clin Investig. 2014 Jun;18(3):145-9. doi: 10.1515/hmbci-2013-0049.

PMID:
25390010
22.

Effects of different "relaxing" music styles on the autonomic nervous system.

Perez-Lloret S, Diez J, Domé MN, Delvenne AA, Braidot N, Cardinali DP, Vigo DE.

Noise Health. 2014 Sep-Oct;16(72):279-84. doi: 10.4103/1463-1741.140507.

23.

Should we listen to our clock to prevent type 2 diabetes mellitus?

Karthikeyan R, Marimuthu G, Spence DW, Pandi-Perumal SR, BaHammam AS, Brown GM, Cardinali DP.

Diabetes Res Clin Pract. 2014 Nov;106(2):182-90. doi: 10.1016/j.diabres.2014.07.029. Epub 2014 Aug 12. Review.

PMID:
25172521
24.

Melatonin normalizes clinical and biochemical parameters of mild inflammation in diet-induced metabolic syndrome in rats.

Cano Barquilla P, Pagano ES, Jiménez-Ortega V, Fernández-Mateos P, Esquifino AI, Cardinali DP.

J Pineal Res. 2014 Oct;57(3):280-90. doi: 10.1111/jpi.12168. Epub 2014 Sep 2.

PMID:
25113124
25.

Melatonin Therapy in Patients with Alzheimer's Disease.

Cardinali DP, Vigo DE, Olivar N, Vidal MF, Brusco LI.

Antioxidants (Basel). 2014 Apr 10;3(2):245-77. doi: 10.3390/antiox3020245. Review.

26.

Sleep and quality of life in urban poverty: the effect of a slum housing upgrading program.

Simonelli G, Leanza Y, Boilard A, Hyland M, Augustinavicius JL, Cardinali DP, Vallières A, Pérez-Chada D, Vigo DE.

Sleep. 2013 Nov 1;36(11):1669-76. doi: 10.5665/sleep.3124.

27.

Ghrelin and its interactions with growth hormone, leptin and orexins: implications for the sleep-wake cycle and metabolism.

García-García F, Juárez-Aguilar E, Santiago-García J, Cardinali DP.

Sleep Med Rev. 2014 Feb;18(1):89-97. doi: 10.1016/j.smrv.2013.04.003. Epub 2013 Jun 29. Review.

PMID:
23816458
28.

A multi-step pathway connecting short sleep duration to daytime somnolence, reduced attention, and poor academic performance: an exploratory cross-sectional study in teenagers.

Perez-Lloret S, Videla AJ, Richaudeau A, Vigo D, Rossi M, Cardinali DP, Perez-Chada D.

J Clin Sleep Med. 2013 May 15;9(5):469-73. doi: 10.5664/jcsm.2668.

29.

Therapeutic application of melatonin in mild cognitive impairment.

Cardinali DP, Vigo DE, Olivar N, Vidal MF, Furio AM, Brusco LI.

Am J Neurodegener Dis. 2012;1(3):280-91. Epub 2012 Nov 18.

30.

Melatonin may curtail the metabolic syndrome: studies on initial and fully established fructose-induced metabolic syndrome in rats.

Cardinali DP, Bernasconi PA, Reynoso R, Toso CF, Scacchi P.

Int J Mol Sci. 2013 Jan 25;14(2):2502-14. doi: 10.3390/ijms14022502.

31.

Sleep and circadian rhythm dysregulation in schizophrenia.

Monti JM, BaHammam AS, Pandi-Perumal SR, Bromundt V, Spence DW, Cardinali DP, Brown GM.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:209-16. doi: 10.1016/j.pnpbp.2012.12.021. Epub 2013 Jan 11. Review.

PMID:
23318689
32.

Cadmium as an endocrine disruptor: correlation with anterior pituitary redox and circadian clock mechanisms and prevention by melatonin.

Jiménez-Ortega V, Cano Barquilla P, Fernández-Mateos P, Cardinali DP, Esquifino AI.

Free Radic Biol Med. 2012 Dec 15;53(12):2287-97. doi: 10.1016/j.freeradbiomed.2012.10.533. Epub 2012 Oct 17.

PMID:
23085516
33.

Melatonin supplementation decreases prolactin synthesis and release in rat adenohypophysis: correlation with anterior pituitary redox state and circadian clock mechanisms.

Jiménez-Ortega V, Barquilla PC, Pagano ES, Fernández-Mateos P, Esquifino AI, Cardinali DP.

Chronobiol Int. 2012 Oct;29(8):1021-35. doi: 10.3109/07420528.2012.705936. Epub 2012 Aug 14.

PMID:
22891630
34.

Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Pandi-Perumal SR, BaHammam AS, Brown GM, Spence DW, Bharti VK, Kaur C, Hardeland R, Cardinali DP.

Neurotox Res. 2013 Apr;23(3):267-300. doi: 10.1007/s12640-012-9337-4. Epub 2012 Jun 28. Review.

PMID:
22739839
35.

Melatonin and mitochondrial dysfunction in the central nervous system.

Cardinali DP, Pagano ES, Scacchi Bernasconi PA, Reynoso R, Scacchi P.

Horm Behav. 2013 Feb;63(2):322-30. doi: 10.1016/j.yhbeh.2012.02.020. Epub 2012 Feb 25. Review.

PMID:
22391273
36.

Discontinuous versus continuous drinking of ethanol in peripubertal rats: effect on 24-hour pattern of hypophyseal-gonadal axis activity and anterior pituitary oxidative stress.

Fernández-Mateos P, Jiménez-Ortega V, Cano Barquilla P, Cardinali DP, Esquifino AI.

Neuroendocrinology. 2012;96(3):194-203. doi: 10.1159/000334963. Epub 2012 Jan 26.

PMID:
22286266
37.

Disrupted chronobiology of sleep and cytoprotection in obesity: possible therapeutic value of melatonin.

Cardinali DP, Pagano ES, Scacchi Bernasconi PA, Reynoso R, Scacchi P.

Neuro Endocrinol Lett. 2011;32(5):588-606. Review.

PMID:
22167135
38.

Cardiac autonomic activity predicts dominance in verbal over spatial reasoning tasks: results from a preliminary study.

Solernó JI, Chada DP, Guinjoan SM, Lloret SP, Hedderwick A, Vidal MF, Cardinali DP, Vigo DE.

Auton Neurosci. 2012 Apr 3;167(1-2):78-80. doi: 10.1016/j.autneu.2011.10.008. Epub 2011 Nov 25.

PMID:
22118959
39.

Melatonin, immune function and cancer.

Srinivasan V, Pandi-Perumal SR, Brzezinski A, Bhatnagar KP, Cardinali DP.

Recent Pat Endocr Metab Immune Drug Discov. 2011 May;5(2):109-23. Review.

PMID:
22074586
40.

The use of chronobiotics in the resynchronization of the sleep/wake cycle. Therapeutical application in the early phases of Alzheimer's disease.

Cardinali DP, Furio AM, Brusco LI.

Recent Pat Endocr Metab Immune Drug Discov. 2011 May;5(2):80-90. Review.

PMID:
22074583
41.

Melatonin in Chagas' disease. Possible therapeutic value.

Cardinali DP, Alvarez CB.

Medicina (B Aires). 2011;71(5):477-83.

PMID:
22057179
42.

Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

Srinivasan V, Cardinali DP, Srinivasan US, Kaur C, Brown GM, Spence DW, Hardeland R, Pandi-Perumal SR.

Ther Adv Neurol Disord. 2011 Sep;4(5):297-317. doi: 10.1177/1756285611406166.

43.

Melatonin and its analogs in insomnia and depression.

Cardinali DP, Srinivasan V, Brzezinski A, Brown GM.

J Pineal Res. 2012 May;52(4):365-75. doi: 10.1111/j.1600-079X.2011.00962.x. Epub 2011 Sep 23. Review.

PMID:
21951153
44.

Sleep habits, alertness, cortisol levels, and cardiac autonomic activity in short-distance bus drivers: differences between morning and afternoon shifts.

Diez JJ, Vigo DE, Lloret SP, Rigters S, Role N, Cardinali DP, Chada DP.

J Occup Environ Med. 2011 Jul;53(7):806-11. doi: 10.1097/JOM.0b013e318221c6de.

PMID:
21701400
45.

Nonmotor symptoms groups in Parkinson's disease patients: results of a pilot, exploratory study.

Perez Lloret S, Rossi M, Merello M, Rascol O, Cardinali DP.

Parkinsons Dis. 2011;2011:473579. doi: 10.4061/2011/473579. Epub 2011 May 24.

46.

Higher autonomic activation predicts better performance in iowa gambling task.

Drucaroff LJ, Kievit R, Guinjoan SM, Gerschcovich ER, Cerquetti D, Leiguarda R, Cardinali DP, Vigo DE.

Cogn Behav Neurol. 2011 Jun;24(2):93-8. doi: 10.1097/WNN.0b013e3182239308.

PMID:
21677576
47.

Melatonin in mitochondrial dysfunction and related disorders.

Srinivasan V, Spence DW, Pandi-Perumal SR, Brown GM, Cardinali DP.

Int J Alzheimers Dis. 2011;2011:326320. doi: 10.4061/2011/326320. Epub 2011 May 4.

48.

Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?

Srinivasan V, Brzezinski A, Pandi-Perumal SR, Spence DW, Cardinali DP, Brown GM.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):913-23. doi: 10.1016/j.pnpbp.2011.03.013. Epub 2011 Mar 29. Review.

PMID:
21453740
49.

Cadmium-Induced Disruption in 24-h Expression of Clock and Redox Enzyme Genes in Rat Medial Basal Hypothalamus: Prevention by Melatonin.

Jiménez-Ortega V, Cano-Barquilla P, Scacchi PA, Cardinali DP, Esquifino AI.

Front Neurol. 2011 Mar 16;2:13. doi: 10.3389/fneur.2011.00013. eCollection 2011.

50.

Clinical aspects of melatonin intervention in Alzheimer's disease progression.

Cardinali DP, Furio AM, Brusco LI.

Curr Neuropharmacol. 2010 Sep;8(3):218-27. doi: 10.2174/157015910792246209.

Supplemental Content

Loading ...
Support Center